| 1 |
30038944 | The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy. | 2018 |
2 |
| 2 |
28450158 | The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer. | 2017 Aug 1 |
4 |
| 3 |
27105861 | Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024(Enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin. | 2016 Aug |
1 |
| 4 |
24518515 | EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer. | 2014 Mar |
6 |
| 5 |
12917209 | The cyclooxygenase 2-specific nonsteroidal anti-inflammatory drugs celecoxib and nimesulide inhibit androgen receptor activity via induction of c-Jun in prostate cancer cells. | 2003 Aug |
1 |